BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer

BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancer. Cancer Research. 76:6320-6330.